Loading clinical trials...
Loading clinical trials...
The study was planned as a single-center, prospective randomized controlled study. Individuals over 65 years of age with type 2 diabetes without severe cognitive impairment will be included in the stu...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Istanbul University - Cerrahpasa
NCT07590193 · Diabetes Mellitus, Type 2
NCT06347315 · Mild Cognitive Impairment
NCT07652775 · Mild Cognitive Impairment (MCI), Depressive Symptoms
NCT06574035 · Diabetes Mellitus, Type 2, Depressive Symptoms, and more
NCT02861781 · Obesity, Insulin Resistance, and more
Istanbul University-Cerrahpasa, Florence Nightingale Faculty of Nursing
Istanbul, Avcılar
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions